317 related articles for article (PubMed ID: 24006485)
1. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
3. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
4. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.
Taylor MA; Davuluri G; Parvani JG; Schiemann BJ; Wendt MK; Plow EF; Schiemann WP; Sossey-Alaoui K
Breast Cancer Res Treat; 2013 Nov; 142(2):341-53. PubMed ID: 24197660
[TBL] [Abstract][Full Text] [Related]
5. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
6. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer.
Wendt MK; Schiemann BJ; Parvani JG; Lee YH; Kang Y; Schiemann WP
Oncogene; 2013 Apr; 32(16):2005-15. PubMed ID: 22710711
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer.
Salvo E; Garasa S; Dotor J; Morales X; Peláez R; Altevogt P; Rouzaut A
Mol Cancer; 2014 May; 13():112. PubMed ID: 24884715
[TBL] [Abstract][Full Text] [Related]
10. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
12. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.
Hong SK; Park JR; Kwon OS; Kim KT; Bae GY; Cha HJ
Cancer Lett; 2016 Jul; 376(2):339-46. PubMed ID: 27085460
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
14. Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer.
Bui T; Rennhack J; Mok S; Ling C; Perez M; Roccamo J; Andrechek ER; Moraes C; Muller WJ
Cell Rep; 2019 Oct; 29(3):589-602.e6. PubMed ID: 31618629
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.
Wendt MK; Taylor MA; Schiemann BJ; Schiemann WP
Mol Biol Cell; 2011 Jul; 22(14):2423-35. PubMed ID: 21613543
[TBL] [Abstract][Full Text] [Related]
16. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
[TBL] [Abstract][Full Text] [Related]
17. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
Galliher-Beckley AJ; Schiemann WP
Carcinogenesis; 2008 Feb; 29(2):244-51. PubMed ID: 18174260
[TBL] [Abstract][Full Text] [Related]
18. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
[TBL] [Abstract][Full Text] [Related]
19. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
